Samsung Next invests in bold and ambitious founders, focusing on transformative innovations in AI, intelligent machines, healthtech, consumer services, and frontier technology.

CG Health Ventures provides investment and support to innovative start ups. We have a particular interest in the fields of Health IT, Digital Health and Genomics, where we look for projects that address real needs in attractive markets. We typically invest in the project early, sometimes even at concept stage. We look for entrepreneurs who have grand ambitions and will not give up easily on achieving their dreams. We believe in the importance of values fit; we want to work effectively together but also have fun along the way. We prioritize projects to which we can add value through our engagement, passion, experience and network, as we like to roll up our sleeves to support the entrepreneur throughout their journeys. We think global, but our network and experience is concentrated in Europe and the US.

Rapidemic is a Dutch-Danish diagnostic company based in Leiden, the Netherlands. The company was spun out of an MIT-award winning international synthetic biology competition in 2021. Rapidemic is on a mission to make quality diagnostics accessible to all worldwide and revolutionize molecular diagnostics with RapiDetect™️, world's first equipment-free molecular diagnostic test platform for infectious diseases. Our first test under development is a 15-minute test for reliable diagnosis of highly prevalent sexually transmitted infections. Rapidemic is backed by the prestigious BioInnovation Institute in Copenhagen and has received over 2,7M$ from the Gates Foundation to respond to the urgent need for better diagnostics for sexual and women's health.

Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simulations to accelerate and de-risk drug development. The company's software combines data points from across the clinical and drug development spectrum and predicts patient response to both approved and novel therapies, allowing pharma and biotech customers to run variations of their clinical trials to improve the trial design and increase the probability of trial success, enabling healthcare industry in the discovery of new clinical opportunities and improve strategies.

Idonia es una compañía especializada en el desarrollo de soluciones software para el sector sanitario y servicios. Trabajamos para facilitar la integración de las imágenes médicas en los estándares que marcan las tecnologías de la información aplicadas a la salud, sin perder nunca el foco en nuestro objetivo: la satisfacción del paciente y de los profesionales que contribuyen en mejorar su calidad de vida.

Welcome to Switzerland’s leading launchpad for early stage healthtech ventures. We accelerate high-potential, early-stage ventures at the intersection of healthtech with the life science industry. DayOne is based in Basel – strategically positioned at the heart of Europe’s leading life sciences ecosystem. By providing a comprehensive support system and facilitating access to industry leaders, experienced mentors and a strong network of partners and investors in the life science sector, we help our portfolio companies overcome early-stage challenges, secure financing, and scale their innovations.

Galen Growth helps healthcare organisations make more informed decisions about Digital Health innovation. We support corporate innovation, strategy, partnership and investment teams answering critical questions: Where is the market moving? Which companies and technologies matter? Which partners are ready to scale? Where are competitors placing their bets? What should we build, buy, partner with or invest in? Our work is powered by HealthTech Alpha, Galen Growth’s proprietary Digital Health intelligence platform. It combines globally structured company, product, funding, partnership, clinical, regulatory and market data with a specialist taxonomy and more than a decade of Digital Health expertise. Organisations use Galen Growth for market mapping, innovation scouting, partner identification, competitive intelligence, corporate venture strategy, M&A screening, commercial due diligence and portfolio assessment. We work with healthcare companies, investors, health systems and professional-services firms that need evidence they can defend—not simply more information. Contact Galen Growth to discuss your strategic question, request a HealthTech Alpha demonstration or commission a decision-grade market analysis.

Innitius is a medtech company focused on bringing a new diagnostic dimension to women’s health through cervical biomechanics. Our platform combines a CE-marked medical device with AI-based decision support to provide objective and quantitative assessment of cervical tissue, complementing existing ultrasound-based approaches. Designed to complement ultrasound, the technology captures biomechanical changes that are not visible through imaging alone. The company works with a growing network of leading hospitals across Europe and is expanding its clinical programs through multicenter studies across different applications in OBGYN. Innitius is advancing clinical validation while progressively scaling its presence in clinical practice.

Este perfil esta inactivo. Si quieres enterarte de todas las novedades. Síguenos en el perfil de Vithas

Voloridge is a quantitative investment management firm built upon a foundation of collaboration. Our team includes award-winning researchers, skilled data analysts, cutting-edge technologists and financial professionals who understand that our success is due to the remarkable way we work together. Our team is made of relentless innovators on a quest to create value for our investors. We strive to operate at a high level of integrity and spend our days solving complex problems in a sophisticated quantitative environment. Our mission is to “Deliver superior risk-adjusted returns driven by an entrepreneurial environment that inspires unyielding passion, imagination, and commitment to excellence.”

Committed to providing 24x7 availability of world-class medical facilities backed by expertise and excellence. Upgrade your Healthcare experience with Aster Royal Al Raffah Hospital, Oman. https://www.aster.om/ Licence No. - 252161/2025 98550066

Bessemer Venture Partners helps entrepreneurs lay strong foundations from inception to build long-standing companies. With more than 155 IPOs and 450-plus portfolio companies across industries, Bessemer supports founders and CEOs from seed through every stage of growth. Bessemer has backed industry defining companies including Anthropic, Abridge, Canva, LinkedIn, Perplexity, Pinterest, RocketLab, Shopify, ServiceTitan, Toast, and Twilio, and has $20 billion of assets under management. Bessemer invests globally, with investment teams located in San Francisco, Silicon Valley, New York, Boston, London, Bangalore, and Tel Aviv.

The Royal Society of Medicine is a leading provider of continuing learning to healthcare professionals. Our vision: better healthcare for better lives. If you have an interest in medicine and healthcare, want to connect with your community and access a raft of career and learning opportunities – then the RSM is for you.

CliniNote unlocks the power of clinical data with innovative tools for healthcare providers and the pharmaceutical industry. Our AI-Agents deliver real-time, high-quality, interoperable data to enhance research, drug development, market access, and patient care—all without burdening clinicians or altering existing workflows and hospital systems. Powered by AI and NLP, the CliniNote Assistant helps doctors create clinical notes while effortlessly capturing comprehensive data. This boosts efficiency and creates previously unavailable Real-World Data points without additional effort from medical professionals or changes to existing processes and systems. We automate data entry for #ClinicalTrials and support clinicians with prospective #AI and #NLP data creation, reducing burdens and enhancing #dataquality. Our commitment ensures the highest quality #RealWorldData collection. We collaborate with healthcare providers (#HCP), site management organizations (#SMO), the pharmaceutical industry, contract research organizations (#CRO), regulators, and healthcare system institutions (#HCS). Our mission is to introduce methods and tools that drastically improve the efficiency of working with clinical data, driving forward advancements in healthcare. #realworldevidence #realworlddata #healthcaredata #precisiononcology #NLP #ontology #datascience #dataanalytics #AI #machinelearning #decisionsupport #bigdata #analytics #AdvancedAnalytics #healthtech #innovation #digitalhealth

HealthCap is a general and professional liability insurance company owned and governed by the long term care providers we insure. HealthCap provides liability insurance products, risk management services, and accredited education to nursing homes, assisted living facilities, and continuing care retirement communities. There are three pillars to HealthCap's success: -Member Ownership -Risk Management -Claims Expertise HealthCap is owned and governed by its members, the senior care facilities that we insure. All profits accrue to the benefits of our members, with excess profits returned as dividends at the discretion of the board of directors. Since our formation in 2001, HealthCap has grown to become a top-3 liability insurance provider to the industry, with over 1,700 insured facilities. HealthCap has built significant financial strength, with more than $250 million in assets and more than $50 million in equity, one of the largest commitments in the insurance industry to senior care. HealthCap is rated "A (Exceptional)"​ by Demotech, Inc., meeting the insurance rating requirements of HUD.

Kilo Health is a leader in the digital health and wellness sector, with over 6,5 million customers worldwide. Since 2021, it was listed as the second fastest-growing company in Europe by Financial Times FT 1,000 and the second-fastest-growing company in Central Europe on the Deloitte Technology Fast 50 list. Kilo Health was also acknowledged by Verslo Žinios as the #1 Lithuanian company in the technology sector in 2022. Currently, the company has 600+ experts and offices across 5 European cities. Kilo Health’s portfolio contains over 30 innovative digital health products in chronic disease management, mental health improvement, and healthy habit change. The company also runs the startup accelerator Kilo Ventures, startup incubator Kilo Co-Found, upskilling program Kilo Academy, and offers its products to business clients. Since 2021, Kilo Health has been a member of the DTx Alliance, Matter Community, and HealthXL.

Hyper is redefining how mission-critical infrastructure gets built. Through HyperSpace, we connect underutilized U.S.-based manufacturing capacity with hyperscale and AI infrastructure operators, enabling faster delivery, greater flexibility, and purpose-built equipment designed for today’s high-density workloads. We work closely with customers and manufacturing partners from design through delivery, removing friction, solving real production challenges, and helping scale infrastructure to meet accelerating AI demand.

Aisthesis Medical is a MedTech startup revolutionizing acute and critical care with VIOSync, an AI-powered clinical decision-support system that predicts sepsis, hypotension, and multi-organ dysfunction before clinical deterioration occurs. By integrating EHRs, wearable devices, and bedside monitors, VIOSync creates a digital twin for each patient, providing real-time, explainable predictive analytics to enhance decision-making. Designed for seamless adoption, VIOSync not only detects risks early but also aligns with evidence-based protocols to guide interventions, improving patient outcomes, reducing ICU admissions, and streamlining hospital workflows. With a focus on high-risk, undermonitored settings, we are redefining how hospitals predict and manage critical conditions before they escalate.

Elaia is a full stack tech and deep tech investor. We partner with ambitious entrepreneurs from inception to leadership, helping them navigate the future and the unknown. For over twenty years, we have combined deep scientific and technological expertise with decades of operational experience to back those building tomorrow. Our joint venture with Lazard, Lazard Elaia Capital, enables us to support exceptional founders at any stage. From our offices in Paris, Barcelona and Tel Aviv, we have been active partners with over 100 startups including Criteo, Mirakl, Shift Technology, AQEMIA and Alice & Bob.

ZKN is de branchevereniging van klinieken in Nederland. We vertegenwoordigen 101 leden met bijna 440 locaties in ons land. Onze leden leveren 80 à 90% van de totale verzekerde kliniekzorg in Nederland. Je vindt ze op www.kliniekzoeker.nl. Onze leden hebben allemaal een ZKN-keurmerk, waarop zij jaarlijks worden getoetst. Hiermee voldoen zij aan strenge eisen op het gebied van kwaliteits-, veiligheids- en risicomanagement. Als branchevereniging ZKN maken wij ons hard voor tijdige zorg voor iedereen die dit nodig heeft, met een belangrijke bijdrage van klinieken als dé plek voor planbare zorg. Zo kunnen zij maximaal bijdragen aan toegankelijkheid van zorg in ons land. Wij behartigen de belangen van zelfstandige klinieken, we zorgen voor een eigen cao én we ondersteunen onze leden met informatievoorziening en inspiratie. Klinieken, of zelfstandige behandelcentra (zbc’s), zijn zorgorganisaties – groot en klein – die focussen op één of een beperkt aantal zorggebieden in de medisch-specialistische zorg. Ze leggen zich toe op veelvoorkomende, planbare ingrepen, zijn goed in wat ze doen en hebben strak georganiseerde werkprocessen.

Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs. Develops a line of diagnostic and therapeutic products for diabetics. Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside the box". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.

AICURA is a leading data and AI company with a focus on healthcare and life sciences. With a mission to enhance patient outcomes, AICURA has built a secure and collaborative data and AI ecosystem. The AICURA platform simplifies the process of data aggregation, exploration, and curation, and leverages AI for automated data analysis and predictive models. AICURA connects various stakeholders, including biotech firms, healthcare providers, medtech companies, clinical researchers, and Contract Research Organizations (CROs), establishing a comprehensive network for data, technology, and knowledge transfer across the healthcare industry. This ecosystem accelerates scalable data-driven research, expedites and de-risks drug development, improves patient care, and fosters AI-based product innovation, paving the way for better treatment options for patients.

Clinica especializada en el diagnóstico del cáncer de piel y otras lesiones pigmentarias. Utilizamos equipos de diagnostico de última generación. Pioneros en el diagnóstico del cáncer. Con un equipo médico de reconocimiento mundial en lesiones pigmentarias, melanoma, carcinoma... Tambien tratamientos postoperacion, de rejuvenecimiento, dermocosmetica, melasma, hipersudoracion, vitaminas.

Fund F is a European pre-seed venture capital fund based in Vienna, managing €28 million and investing in technology-driven startups with gender-diverse founding teams across Europe. We are sector-agnostic and back ambitious founders building globally relevant companies, with particular expertise in ClimateTech and HealthTech. Our investment thesis is rooted in the belief that diverse teams build better businesses and deliver stronger returns. Beyond capital, we work closely with our founders, providing hands-on support, access to an extensive network of investors, operators, and industry experts, and a collaborative portfolio community. Today, the Fund F portfolio includes 26 startups across a broad range of technology sectors, united by bold ambitions and the potential to create category-defining companies.

FormlyAI is a specialized AI-powered software platform that simplifies and streamlines medical device certification and compliance, with a focus on startups and smaller firms.